Chapter Six. Squandering R & D Resources
It isn’t that they can’t see the solution. It’s that they can’t see the problem. | ||
| --G.K. Chesterton | ||
The system through which medicines make it to the market in the Unites States has gone terribly awry. It’s not just that the big successes of the 1980s and 1990s in developing blockbuster drugs are not sustainable, as the drought in new drugs approved by the FDA reveals. It’s not just that the “low-hanging fruit has been picked” or that the easy drugs have already been developed. No, the problem is much more serious.
The system certainly does not lack resources. Collectively, drug firms spend tens of billions of dollars each year on research. The National Science Foundation estimated spending at $31 billion ...
Get Reasonable Rx: Solving the Drug Price Crisis now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
